TrialPanorama/TrialPanorama-database huggingface dataset:
Study 33561312 — Predictive Biomarker (PRD): KRAS mRNA
Genes: KRAS; KRAS2; RASK2
Study 32732500 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Complement C3
Genes: C3; CPAMD1
Study 32732500 — Pharmacodynamic Biomarker (PDY): Complement C5
Genes: C5; CPAMD4
Study 33596972 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 34082801 — Predictive Biomarker (PRD): SMS mRNA
Genes: SMS
Study 36271391 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 32423348 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 32423348 — Surrogate Endpoint (SUR): Blood pressure
Study 32423348 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 32423348 — Safety Biomarker (SAF): Cardiac troponin I
Genes: TNNI3; TNNC1
Study 32423348 — Safety Biomarker (SAF): B-type natriuretic peptide
Genes: NPPB
Study 35979048 — Predictive Biomarker (PRD): SDS mRNA
Genes: SDS; SDH
Study 33515503 — Predictive Biomarker (PRD): MAGI1 mRNA
Genes: MAGI1; AIP3; BAIAP1; BAP1; TNRC19
Study 33515503 — Predictive Biomarker (PRD): BRCA1 mRNA
Genes: BRCA1; RNF53
Study 33515503 — Predictive Biomarker (PRD): Homologous recombination deficiency
Study 35059823 — Predictive Biomarker (PRD): C2 mRNA
Genes: C2
Study 33572546 — Predictive Biomarker (PRD): NF2 mRNA
Genes: NF2; SCH
Study 35872697 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 35872697 — Pharmacodynamic Biomarker (PDY): High density lipoprotein cholesterol
Study 33122315 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Monitoring Biomarker (MOI): Vitamin B12
Study 32019855 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study 33734452 — Predictive Biomarker (PRD): Arginine vasopressin
Genes: AVP; ARVP; VP
Study 32772571 — Predictive Biomarker (PRD): TAT mRNA
Genes: TAT
Study 32206785 — Predictive Biomarker (PRD): EPX mRNA
Genes: EPX; EPER; EPO; EPP
Study 35306340 — Monitoring Biomarker (MOI): Cell-free DNA
Study 32065760 — Safety Biomarker (SAF): B-type natriuretic peptide
Genes: NPPB
Study 34989797 — Predictive Biomarker (PRD): TG mRNA
Genes: TG
Study 34989797 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Free fatty acids
Study 34989797 — Pharmacodynamic Biomarker (PDY): High density lipoprotein cholesterol
Study 34989797 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 33561968 — Surrogate Endpoint (SUR): Urinary cystine
Study 35255077 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 35681696 — Predictive Biomarker (PRD): BRCA1 mRNA
Genes: BRCA1; RNF53
Study 35681696 — Predictive Biomarker (PRD): BRCA2 mRNA
Genes: BRCA2; FACD; FANCD1
Study 35681696 — Predictive Biomarker (PRD): PALB2 mRNA
Genes: PALB2; FANCN
Study 35681696 — Predictive Biomarker (PRD): CHEK2 mRNA
Genes: CHEK2; CDS1; CHK2; RAD53
Study 32366293 — Predictive Biomarker (PRD): RANGAP1 mRNA
Genes: RANGAP1; KIAA1835; SD
Study 35652260 — Predictive Biomarker (PRD): SHBG mRNA
Genes: SHBG
Study 35782695 — Predictive Biomarker (PRD): C6 mRNA
Genes: C6
Study 35782695 — Monitoring Biomarker (MOI): Complement C7
Genes: C7
Study 35782695 — Predictive Biomarker (PRD): CDCA3 mRNA
Genes: CDCA3; C8; GRCC8; TOME1
Study 35782695 — Predictive Biomarker (PRD): TRAPPC9 mRNA
Genes: TRAPPC9; KIAA1882; NIBP; T1
Study 35093230 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study 33619579 — Surrogate Endpoint (SUR): Blood pressure
Study 35175967 — Predictive Biomarker (PRD): Programmed cell death 1 ligand 1
Genes: CD274; B7H1; PDCD1L1; PDCD1LG1; PDL1
Study 36490309 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study 33675081 — Surrogate Endpoint (SUR): Blood pressure
Study 34959840 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 35485332 — Predictive Biomarker (PRD): ISG15 mRNA
Genes: ISG15; G1P2; UCRP
Study 35485332 — Predictive Biomarker (PRD): MX1 mRNA
Genes: MX1
Study 35485332 — Predictive Biomarker (PRD): OAS1 mRNA
Genes: OAS1; OIAS
Study 35810356 — Predictive Biomarker (PRD): CCP110 mRNA
Genes: CCP110; CEP110; CP110; KIAA0419
Study 35810356 — Predictive Biomarker (PRD): FOXJ1 mRNA
Genes: FOXJ1; FKHL13; HFH4
Study 32727540 — Monitoring Biomarker (MOI): Tissue transglutaminase
Genes: TGM2
Study 33908301 — Predictive Biomarker (PRD): CXCR1 mRNA
Genes: CXCR1; CMKAR1; IL8RA
Study 33908301 — Safety Biomarker (SAF): miR-375
Genes: MIR375
Study 35286921 — Predictive Biomarker (PRD): FGR mRNA
Genes: FGR; SRC2
Study 35483209 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 35483209 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 35483209 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study 34146100 — Surrogate Endpoint (SUR): Neutralizing antibody
Study 34435472 — Predictive Biomarker (PRD): PPA1 mRNA
Genes: PPA1; IOPPP; PP
Study 33239409 — Surrogate Endpoint (SUR): Serum potassium
Study 33203692 — Predictive Biomarker (PRD): RARA mRNA
Genes: RARA; NR1B1
Study 33118727 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): Endothelin-1
Genes: EDN1
Study 33118727 — Safety Biomarker (SAF): von Willebrand factor
Genes: VWF; F8VWF
Study 33127947 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 33127947 — Predictive Biomarker (PRD): CD14 mRNA
Genes: CD14
Study 33127947 — Predictive Biomarker (PRD): RORC mRNA
Genes: RORC; NR1F3; RORG; RZRG
Study 34455801 — Predictive Biomarker (PRD): CP mRNA
Genes: CP
Study 36027558 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study 36027558 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study 36027558 — Predictive Biomarker (PRD): Hormone receptor
Study 34099068 — Predictive Biomarker (PRD): TMBIM1 mRNA
Genes: TMBIM1; LFG3; RECS1; PP1201; PSEC0158
Study 32068603 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study 32068603 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study 32803798 — Surrogate Endpoint (SUR): Probing pocket depth
Study 32471973 — Predictive Biomarker (PRD): TACR1 mRNA
Genes: TACR1; NK1R; TAC1R
Study 32471973 — Surrogate Endpoint (SUR): Blood pressure
Study 32471973 — Pharmacodynamic Biomarker (PDY): Extracellular signal-regulated kinase
Study 32279561 — Predictive Biomarker (PRD); Safety Biomarker (SAF): DES mRNA
Genes: DES
Study 33879806 — Safety Biomarker (SAF): miR-150-5p
Genes: MIR150
Study 33879806 — Predictive Biomarker (PRD); Safety Biomarker (SAF): miR-150
Genes: MIR150
Study 32014855 — Predictive Biomarker (PRD): CFTR mRNA
Genes: CFTR; ABCC7
Study 32014855 — Predictive Biomarker (PRD): HFE mRNA
Genes: HFE; HLAH
Study 32014855 — Predictive Biomarker (PRD): PLG mRNA
Genes: PLG
Study 33511816 — Predictive Biomarker (PRD): RPE mRNA
Genes: RPE; HUSSY-17
Study 33511816 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study 33511816 — Surrogate Endpoint (SUR): Blood pressure
Study 33334571 — Predictive Biomarker (PRD): ALK tyrosine kinase receptor
Genes: ALK
Study 35781594 — Predictive Biomarker (PRD): PLA1A mRNA
Genes: PLA1A; NMD; PSPLA1
Study 32591573 — Surrogate Endpoint (SUR): Bone mineral density
Study 35275991 — Predictive Biomarker (PRD): ALK tyrosine kinase receptor
Genes: ALK
Study 35275991 — Monitoring Biomarker (MOI): Cell-free DNA
Study 34130883 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study 34398956 — Predictive Biomarker (PRD): RALA mRNA
Genes: RALA; RAL
Study 34398956 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 34921525 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study 34921525 — Safety Biomarker (SAF): miR-30c
Study 34921525 — Predictive Biomarker (PRD): miR-31
Genes: MIR31
Study 32210157 — Predictive Biomarker (PRD): Estrogen receptor
Genes: ESR1; ESR; NR3A1
Study 32210157 — Predictive Biomarker (PRD): Ki-67
Genes: MKI67; MIB-1; PPP1R105
Study 32210157 — Predictive Biomarker (PRD): Hormone receptor
Study 35976944 — Predictive Biomarker (PRD): MGP mRNA
Genes: MGP; MGLAP; GIG36
Study 36152526 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 32560932 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study 32560932 — Predictive Biomarker (PRD): SERPINF1 mRNA
Genes: SERPINF1; PEDF; PIG35
Study 32560932 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study 34551995 — Surrogate Endpoint (SUR): Serum creatinine
Study 35863693 — Predictive Biomarker (PRD): CCR7 mRNA
Genes: CCR7; CMKBR7; EBI1; EVI1
Study 35863693 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 32156842 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 35972211 — Predictive Biomarker (PRD): Interleukin 5
Genes: IL5
Study 34332788 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 34332788 — Pharmacodynamic Biomarker (PDY): High density lipoprotein cholesterol
Study 35522325 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study 33904781 — Surrogate Endpoint (SUR): Blood pressure
Study 32759236 — Predictive Biomarker (PRD): NOTCH1 mRNA
Genes: NOTCH1; TAN1
Study 32759236 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study 33457425 — Surrogate Endpoint (SUR): Blood pressure
Study 32905642 — Predictive Biomarker (PRD): WT1 mRNA
Genes: WT1
Study 34619106 — Predictive Biomarker (PRD): SLC5A2 mRNA
Genes: SLC5A2; SGLT2
Study 33020051 — Surrogate Endpoint (SUR): Blood pressure
Study 34994685 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study 35759826 — Surrogate Endpoint (SUR): Blood pressure
Study 34386597 — Surrogate Endpoint (SUR): Serum creatinine
Study 34372849 — Surrogate Endpoint (SUR): Blood pressure
Study 32028804 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 34716085 — Surrogate Endpoint (SUR): Neutralizing antibody
Study 35483093 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study 32505378 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 35385395 — Surrogate Endpoint (SUR): Blood pressure
Study 35365139 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study 33756250 — Predictive Biomarker (PRD): PC mRNA
Genes: PC
Study 33756250 — Pharmacodynamic Biomarker (PDY): Superoxide dismutase Cu-Zn
Genes: SOD1
Study 33756250 — Monitoring Biomarker (MOI): Heme oxygenase 1
Genes: HMOX1; HO; HO1
Study 32620917 — Predictive Biomarker (PRD): MLH1 mRNA
Genes: MLH1; COCA2
Study 32620917 — Predictive Biomarker (PRD): RNF43 mRNA
Genes: RNF43
Study 32620917 — Predictive Biomarker (PRD): PIK3CA mRNA
Genes: PIK3CA
Study 32620917 — Predictive Biomarker (PRD): BRCA2 mRNA
Genes: BRCA2; FACD; FANCD1
Study 32620917 — Predictive Biomarker (PRD): APC mRNA
Genes: APC; DP2.5
Study 32620917 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Cellular tumor antigen p53
Genes: TP53; P53
Study 32620917 — Predictive Biomarker (PRD); Safety Biomarker (SAF): PIK3CA
Genes: PI3K
Study 32620917 — Predictive Biomarker (PRD); Safety Biomarker (SAF): CTNNB1 mRNA
Genes: CTNNB1; CTNNB; OK/SW-cl.35; PRO2286
Study 32620917 — Predictive Biomarker (PRD): KRAS mRNA
Genes: KRAS; KRAS2; RASK2
Study 32620917 — Predictive Biomarker (PRD): TGFBR2 mRNA
Genes: TGFBR2
Study 32620917 — Predictive Biomarker (PRD): Microsatellite instability
Study 36174744 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Monitoring Biomarker (MOI): Vitamin B12
Study 35175317 — Predictive Biomarker (PRD): CNP mRNA
Genes: CNP
Study 33069714 — Predictive Biomarker (PRD): DNMT1 mRNA
Genes: DNMT1; AIM; CXXC9; DNMT
Study 33069714 — Predictive Biomarker (PRD): DNMT3A mRNA
Genes: DNMT3A
Study 33069714 — Predictive Biomarker (PRD): DNMT3B mRNA
Genes: DNMT3B
Study 33069714 — Predictive Biomarker (PRD): TET1 mRNA
Genes: TET1; CXXC6; KIAA1676; LCX
Study 33069714 — Predictive Biomarker (PRD): TET2 mRNA
Genes: TET2; KIAA1546; Nbla00191
Study 33069714 — Predictive Biomarker (PRD): TET3 mRNA
Genes: TET3; KIAA0401
Study 35708706 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study 35708706 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study 32228238 — Surrogate Endpoint (SUR): Blood pressure
Study 35437929 — Surrogate Endpoint (SUR): Blood pressure
Study 32910197 — Predictive Biomarker (PRD): MSC mRNA
Genes: MSC; ABF1; BHLHA22
Study 35430680 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 32688143 — Pharmacodynamic Biomarker (PDY): Huntingtin
Genes: HTT; HD; IT15
Study 33358790 — Predictive Biomarker (PRD): CP mRNA
Genes: CP
Study 33358790 — Predictive Biomarker (PRD): CCS mRNA
Genes: CCS
Study 32942924 — Predictive Biomarker (PRD): HFE mRNA
Genes: HFE; HLAH
Study 33121228 — Surrogate Endpoint (SUR): Blood pressure
Study 35224034 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 35224034 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study 34235608 — Predictive Biomarker (PRD): PRCP mRNA
Genes: PRCP; PCP
Study 32186106 — Predictive Biomarker (PRD): RPE mRNA
Genes: RPE; HUSSY-17
Study 36494329 — Pharmacodynamic Biomarker (PDY): Huntingtin
Genes: HTT; HD; IT15
Study 34065454 — Surrogate Endpoint (SUR): Blood pressure
Study 35300814 — Predictive Biomarker (PRD): LPAR4 mRNA
Genes: LPAR4; GPR23; LPA4; P2RY9
Study 35300814 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 33125080 — Predictive Biomarker (PRD): IGF1 mRNA
Genes: IGF1; IBP1
Study 33125080 — Predictive Biomarker (PRD): IGFBP2 mRNA
Genes: IGFBP2; BP2; IBP2
Study 33125080 — Predictive Biomarker (PRD): IGFBP4 mRNA
Genes: IGFBP4; IBP4
Study 33125080 — Predictive Biomarker (PRD): IGFBP6 mRNA
Genes: IGFBP6; IBP6
Study 33125080 — Predictive Biomarker (PRD): IGFBP7 mRNA
Genes: IGFBP7; MAC25; PSF
Study 33125080 — Predictive Biomarker (PRD): IGFBP1 mRNA
Genes: IGFBP1; IBP1
Study 33125080 — Predictive Biomarker (PRD): IGFBP3 mRNA
Genes: IGFBP3; IBP3
Study 35337143 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 35337143 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): D-dimer
Study 33411684 — Pharmacodynamic Biomarker (PDY): Ataxin-2
Genes: ATXN2; ATX2; SCA2; TNRC13
Study 32441643 — Predictive Biomarker (PRD): Estrogen receptor
Genes: ESR1; ESR; NR3A1
Study 32690008 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study 32569126 — Predictive Biomarker (PRD): HTR2A mRNA
Genes: HTR2A; HTR2
Study 32569126 — Predictive Biomarker (PRD): CYP1A2 mRNA
Genes: CYP1A2
Study 33379851 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 33379851 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study 33379851 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study 33151286 — Predictive Biomarker (PRD): Indoleamine 2,3-dioxygenase 1
Genes: IDO1; IDO; INDO
Study 33151286 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study 35574743 — Surrogate Endpoint (SUR): Blood pressure
Study 32065000 — Safety Biomarker (SAF): Cytochrome P450 2C19
Genes: CYP2C19
Study 32065000 — Predictive Biomarker (PRD): CYP3A4 mRNA
Genes: CYP3A4; CYP3A3
Study 35400584 — Predictive Biomarker (PRD): Proto-oncogene c-Met
Genes: MET
Study 35400584 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study 35400584 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Hepatocyte growth factor
Genes: HGF; HPTA
Study 36270309 — Pharmacodynamic Biomarker (PDY): High-frequency oscillations
Study 32016466 — Predictive Biomarker (PRD): SLC2A1 mRNA
Genes: SLC2A1; GLUT1
Study 35791276 — Safety Biomarker (SAF): B-type natriuretic peptide
Genes: NPPB
Study 32741099 — Predictive Biomarker (PRD): Glutamate carboxypeptidase II
Genes: FOLH1; FOLH; NAALAD1; PSM; PSMA; GIG27
Study 34446053 — Predictive Biomarker (PRD): GCNT2 mRNA
Genes: GCNT2; GCNT5; II; NACGT1
Study 34446053 — Predictive Biomarker (PRD): CCL20 mRNA
Genes: CCL20; LARC; MIP3A; SCYA20
Study 36196729 — Predictive Biomarker (PRD): TG mRNA
Genes: TG
Study 32556602 — Predictive Biomarker (PRD): WEE1 mRNA
Genes: WEE1
Study 32155622 — Pharmacodynamic Biomarker (PDY): 5'-AMP-activated protein kinase subunit beta-1
Genes: PRKAB1; AMPK
Study 32155622 — Pharmacodynamic Biomarker (PDY): Insulin receptor substrate 1
Genes: IRS1
Study 35868849 — Predictive Biomarker (PRD): BRCA1 mRNA
Genes: BRCA1; RNF53
Study 35868849 — Predictive Biomarker (PRD): BRCA2 mRNA
Genes: BRCA2; FACD; FANCD1
Study 35868849 — Predictive Biomarker (PRD): PALB2 mRNA
Genes: PALB2; FANCN
Study 34496743 — Predictive Biomarker (PRD): MBL2 mRNA
Genes: MBL2; COLEC1; MBL
Study 32518098 — Pharmacodynamic Biomarker (PDY): 5'-AMP-activated protein kinase subunit beta-1
Genes: PRKAB1; AMPK
Study 32518098 — Predictive Biomarker (PRD): MCTS1 mRNA
Genes: MCTS1; MCT1
Study 32518098 — Predictive Biomarker (PRD): SLC16A4 mRNA
Genes: SLC16A4; MCT4; MCT5
Study 32260470 — Predictive Biomarker (PRD): ABCA1 mRNA
Genes: ABCA1; ABC1; CERP
Study 32423239 — Predictive Biomarker (PRD): MAS1 mRNA
Genes: MAS1; MAS
Study 32915523 — Surrogate Endpoint (SUR): Blood pressure
Study 36346079 — Monitoring Biomarker (MOI): HBV DNA
Study 32729802 — Safety Biomarker (SAF): Cytochrome c
Study 33030064 — Surrogate Endpoint (SUR): Blood pressure
Study 32988525 — Pharmacodynamic Biomarker (PDY): Superoxide dismutase Cu-Zn
Genes: SOD1
Study 32988525 — Safety Biomarker (SAF): Interleukin 2
Genes: IL2
Study 32988525 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 34604936 — Predictive Biomarker (PRD): PISD mRNA
Genes: PISD
Study 32047951 — Surrogate Endpoint (SUR): Bone mineral density
Study 35324270 — Surrogate Endpoint (SUR): Duration of severe neutropenia
Study 35878838 — Surrogate Endpoint (SUR): Blood pressure
Study 34706567 — Pharmacodynamic Biomarker (PDY): Matrix metalloproteinase 9
Genes: MMP9; CLG4B
Study 33054121 — Pharmacodynamic Biomarker (PDY): Tyrosine-protein kinase BTK
Genes: BTK; AGMX1; ATK; BPK
Study 33491438 — Predictive Biomarker (PRD): ACKR1 mRNA
Genes: ACKR1; DARC; FY; GPD
Study 35277011 — Surrogate Endpoint (SUR): Blood pressure
Study 32147060 — Surrogate Endpoint (SUR): Blood pressure
Study 35562713 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study 34803872 — Predictive Biomarker (PRD): HSPB1 mRNA
Genes: HSPB1; HSP27; HSP28
Study 32967430 — Predictive Biomarker (PRD): Exhaled nitric oxide
Study 36456969 — Predictive Biomarker (PRD): SI mRNA
Genes: SI
Study 34237250 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study 33403890 — Surrogate Endpoint (SUR): Blood pressure
Study 33512755 — Pharmacodynamic Biomarker (PDY): Dipeptidyl peptidase 4
Genes: DPP4; ADCP2; CD26
Study 35504446 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study 33734030 — Predictive Biomarker (PRD): CFTR mRNA
Genes: CFTR; ABCC7
Study 35429480 — Predictive Biomarker (PRD): Cyclin-dependent kinase-like 5
Genes: CDKL5; STK9
Study 33998590 — Predictive Biomarker (PRD): LBP mRNA
Genes: LBP
Study 32800391 — Predictive Biomarker (PRD): MIP mRNA
Genes: MIP; AQP0
Study 35258786 — Surrogate Endpoint (SUR): Blood pressure
Study 33934542 — Predictive Biomarker (PRD): ARCN1 mRNA
Genes: ARCN1; COPD
Study 33422431 — Surrogate Endpoint (SUR): Blood pressure
Study 35446628 — Predictive Biomarker (PRD): NPEPPS mRNA
Genes: NPEPPS; PSA
Study 32792359 — Predictive Biomarker (PRD): Programmed cell death 1 ligand 1
Genes: CD274; B7H1; PDCD1L1; PDCD1LG1; PDL1
Study 32792359 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Tumor mutational burden
Study 32792359 — Predictive Biomarker (PRD): Microsatellite instability
Study 35691258 — Predictive Biomarker (PRD): TG mRNA
Genes: TG
Study 33722477 — Predictive Biomarker (PRD): AMH mRNA
Genes: AMH; MIF
Study 35277461 — Safety Biomarker (SAF): PDCD1
Genes: CD279; PD1; hSLE1; PD-1
Study 32840311 — Predictive Biomarker (PRD): SHBG mRNA
Genes: SHBG
Study 34252252 — Safety Biomarker (SAF): Hyaluronic acid
Study 34636852 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study 33432367 — Predictive Biomarker (PRD): Programmed cell death 1 ligand 1
Genes: CD274; B7H1; PDCD1L1; PDCD1LG1; PDL1
Study 32686744 — Predictive Biomarker (PRD): VDR mRNA
Genes: VDR; NR1I1
Study 34334142 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 34334142 — Surrogate Endpoint (SUR): Blood pressure
Study 34865009 — Predictive Biomarker (PRD): MAG mRNA
Genes: MAG; GMA
Study 35402989 — Surrogate Endpoint (SUR): Blood pressure
Study 34117867 — Predictive Biomarker (PRD): PNP mRNA
Genes: PNP; NP
Study 34117867 — Predictive Biomarker (PRD): CFH mRNA
Genes: CFH; HF; HF1; HF2
Study 33480087 — Predictive Biomarker (PRD): MYC mRNA
Genes: MYC; BHLHE39
Study 33480087 — Predictive Biomarker (PRD): Apoptosis regulator Bcl-2
Genes: BCL2
Study 33480087 — Predictive Biomarker (PRD): BCL6 mRNA
Genes: BCL6; BCL5; LAZ3; ZBTB27; ZNF51
Study 33480087 — Predictive Biomarker (PRD): PAX5 mRNA
Genes: PAX5
Study 33480087 — Predictive Biomarker (PRD): CD68 mRNA
Genes: CD68
Study 33480087 — Safety Biomarker (SAF): Hemoglobin scavenger receptor
Genes: CD163; M130
Study 33317479 — Surrogate Endpoint (SUR): Pulmonary vascular resistance
Study 33482902 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 34006508 — Predictive Biomarker (PRD): CNGA3 mRNA
Genes: CNGA3; CNCG3
Study 33040631 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Immunoglobulin E
Study 33040631 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): Interferon gamma
Genes: IFNG
Study 32170867 — Predictive Biomarker (PRD): Leukocyte surface antigen Leu-16
Genes: MS4A1; CD20
Study 36075246 — Predictive Biomarker (PRD): PCSK9 mRNA
Genes: PCSK9; NARC1; PSEC0052
Study 33283485 — Predictive Biomarker (PRD): TTR mRNA
Genes: TTR; PALB
Study 35559241 — Predictive Biomarker (PRD): PCSK7 mRNA
Genes: PCSK7; LPC; PC7; PC8; SPC7
Study 34258270 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 34253679 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Interleukin 8
Genes: CXCL8; IL8
Study 34253679 — Monitoring Biomarker (MOI): Matrix metalloproteinase 8
Genes: MMP8; CLG1
Study 34253679 — Pharmacodynamic Biomarker (PDY): Matrix metalloproteinase 9
Genes: MMP9; CLG4B
Study 35733519 — Predictive Biomarker (PRD): FBXO8 mRNA
Genes: FBXO8; FBS; FBX8; DC10; UNQ1877/PRO4320
Study 33775313 — Predictive Biomarker (PRD): ITGAM mRNA
Genes: ITGAM; CD11B; CR3A